Log In
Print
BCIQ
Print
Print this Print this
 

CR6261

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionMonoclonal antibody (mAb)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsTreat influenza A virus infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today